These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29614689)

  • 21. Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones.
    Schiffer D; Caldera V; Mellai M; Conforti P; Cattaneo E; Zuccato C
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):899-910. PubMed ID: 24634989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
    Flament J; Hantraye P; Valette J
    Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI biomarkers in Huntington's disease.
    van den Bogaard S; Dumas E; van der Grond J; van Buchem M; Roos R
    Front Biosci (Elite Ed); 2012 Jan; 4(5):1910-25. PubMed ID: 22202007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study.
    Romano S; Romano C; Peconi M; Fiore A; Bellucci G; Morena E; Troili F; Cipollini V; Annibali V; Giglio S; Mechelli R; Ferraldeschi M; Veneziano L; Mantuano E; Sani G; Vecchione A; Umeton R; Giubilei F; Salvetti M; Corbo RM; Scarabino D; Ristori G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease.
    Hernández IH; Torres-Peraza J; Santos-Galindo M; Ramos-Morón E; Fernández-Fernández MR; Pérez-Álvarez MJ; Miranda-Vizuete A; Lucas JJ
    Acta Neuropathol; 2017 Dec; 134(6):839-850. PubMed ID: 28861715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioenergetics in Huntington's disease.
    Grünewald T; Beal MF
    Ann N Y Acad Sci; 1999; 893():203-13. PubMed ID: 10672239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
    Besson MT; Dupont P; Fridell YW; Liévens JC
    Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Imaging in Huntington's Disease.
    Wilson H; Politis M
    Int Rev Neurobiol; 2018; 142():289-333. PubMed ID: 30409256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies.
    Rocha NP; Ribeiro FM; Furr-Stimming E; Teixeira AL
    Mediators Inflamm; 2016; 2016():8653132. PubMed ID: 27578922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential biomarkers to follow the progression and treatment response of Huntington's disease.
    Disatnik MH; Joshi AU; Saw NL; Shamloo M; Leavitt BR; Qi X; Mochly-Rosen D
    J Exp Med; 2016 Nov; 213(12):2655-2669. PubMed ID: 27821553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.
    Wagner L; Björkqvist M; Lundh SH; Wolf R; Börgel A; Schlenzig D; Ludwig HH; Rahfeld JU; Leavitt B; Demuth HU; Petersén Å; von Hörsten S
    J Neurochem; 2016 Jun; 137(5):820-37. PubMed ID: 27016395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease.
    Niemela V; Landtblom AM; Nyholm D; Kneider M; Constantinescu R; Paucar M; Svenningsson P; Abujrais S; Burman J; Shevchenko G; Bergquist J; Sundblom J
    Mov Disord; 2021 Feb; 36(2):481-491. PubMed ID: 33247616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
    Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
    Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revelation of the IFNα, IL-10, IL-8 and IL-1β as promising biomarkers reflecting immuno-pathological mechanisms in porcine Huntington's disease model.
    Valekova I; Jarkovska K; Kotrcova E; Bucci J; Ellederova Z; Juhas S; Motlik J; Gadher SJ; Kovarova H
    J Neuroimmunol; 2016 Apr; 293():71-81. PubMed ID: 27049565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Huntington's disease: 4 big questions.
    Nowogrodzki A
    Nature; 2018 May; 557(7707):S48. PubMed ID: 29844555
    [No Abstract]   [Full Text] [Related]  

  • 39. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in Huntington's disease: the search for markers of disease onset and progression.
    Mason S; Barker RA
    J Neurol; 2015 Aug; 262(8):1990-5. PubMed ID: 25794860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.